Cargando…
Collaborative innovation in drug discovery : strategies for public and private partnerships /
Can academia save the pharmaceutical industry? The pharmaceutical industry is at a crossroads. The urgent need for novel therapies cannot stem the skyrocketing costs and plummeting productivity plaguing R & D, and many key products are facing patent expiration. Dr. Rathnam Chaguturu presents a c...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Hoboken, New Jersey :
John Wiley & Sons Inc.,
[2014]
|
| Colección: | Wiley series on technologies for the pharmaceutical industry.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | EBOOKCENTRAL_ocn857664391 | ||
| 003 | OCoLC | ||
| 005 | 20240329122006.0 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 130903s2014 nju ob 001 0 eng | ||
| 010 | |a 2013035811 | ||
| 040 | |a DLC |b eng |e rda |e pn |c DLC |d YDX |d EBLCP |d N$T |d IDEBK |d DG1 |d YDXCP |d E7B |d CUI |d CUS |d CDX |d COO |d RECBK |d OCLCF |d STF |d OCLCQ |d DEBBG |d LOA |d DG1 |d COCUF |d CHVBK |d DEBSZ |d MOR |d CCO |d LIP |d PIFAG |d ZCU |d MERUC |d OCLCQ |d COD |d MERER |d OCLCQ |d NJR |d OCLCO |d OCLCA |d U3W |d OCLCQ |d OCLCO |d OCLCQ |d CASUM |d ICG |d AUD |d VT2 |d OCLCO |d AU@ |d OCLCO |d OCLCQ |d WYU |d OCLCO |d CUY |d OCLCO |d OCLCA |d UWO |d OCLCA |d OCLCQ |d OCLCO |d U3G |d DKC |d OCLCO |d OCLCQ |d UKAHL |d OCLCQ |d DCT |d ADU |d OCLCQ |d OCLCA |d UKCRE |d OCLCO |d OCLCQ |d OCLCO |d OCLCL | ||
| 019 | |a 905856541 |a 929527164 |a 960199933 |a 961650872 |a 962632779 |a 974965052 |a 975045776 |a 988414022 |a 992018887 |a 1017999974 |a 1031885932 |a 1037740970 |a 1041923872 |a 1045523002 |a 1056925437 |a 1067207154 |a 1089249770 |a 1100462787 |a 1113256549 |a 1119117142 |a 1124397447 |a 1148154418 |a 1153462858 |a 1244447908 | ||
| 020 | |a 9781118778128 |q (ePub) | ||
| 020 | |a 111877812X |q (ePub) | ||
| 020 | |a 9781118778159 |q (Adobe PDF) | ||
| 020 | |a 1118778154 |q (Adobe PDF) | ||
| 020 | |a 9781118778166 | ||
| 020 | |a 1118778162 | ||
| 020 | |a 0470917377 | ||
| 020 | |a 9780470917374 | ||
| 020 | |a 9781306571784 | ||
| 020 | |a 1306571782 | ||
| 020 | |a 1118778138 | ||
| 020 | |a 9781118778135 | ||
| 020 | |z 9780470917374 |q (cloth) | ||
| 029 | 1 | |a AU@ |b 000051932344 | |
| 029 | 1 | |a CHBIS |b 010259524 | |
| 029 | 1 | |a CHNEW |b 000942311 | |
| 029 | 1 | |a CHVBK |b 480225966 | |
| 029 | 1 | |a DEBBG |b BV042792988 | |
| 029 | 1 | |a DEBBG |b BV043396198 | |
| 029 | 1 | |a DEBBG |b BV044067649 | |
| 029 | 1 | |a DEBSZ |b 485041537 | |
| 029 | 1 | |a NZ1 |b 15922666 | |
| 029 | 1 | |a NZ1 |b 16097921 | |
| 035 | |a (OCoLC)857664391 |z (OCoLC)905856541 |z (OCoLC)929527164 |z (OCoLC)960199933 |z (OCoLC)961650872 |z (OCoLC)962632779 |z (OCoLC)974965052 |z (OCoLC)975045776 |z (OCoLC)988414022 |z (OCoLC)992018887 |z (OCoLC)1017999974 |z (OCoLC)1031885932 |z (OCoLC)1037740970 |z (OCoLC)1041923872 |z (OCoLC)1045523002 |z (OCoLC)1056925437 |z (OCoLC)1067207154 |z (OCoLC)1089249770 |z (OCoLC)1100462787 |z (OCoLC)1113256549 |z (OCoLC)1119117142 |z (OCoLC)1124397447 |z (OCoLC)1148154418 |z (OCoLC)1153462858 |z (OCoLC)1244447908 | ||
| 037 | |a 1662193 |b EBL | ||
| 042 | |a pcc | ||
| 050 | 0 | 0 | |a RM301.25 |
| 060 | 4 | |a QV 745 | |
| 072 | 7 | |a MED |x 071000 |2 bisacsh | |
| 082 | 0 | 0 | |a 615.1/9 |2 23 |
| 049 | |a UAMI | ||
| 245 | 0 | 0 | |a Collaborative innovation in drug discovery : |b strategies for public and private partnerships / |c edited by Dr. Rathnam Chaguturu. |
| 264 | 1 | |a Hoboken, New Jersey : |b John Wiley & Sons Inc., |c [2014] | |
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Wiley Series on Technologies for the Pharmaceutical Industry | |
| 504 | |a Includes bibliographical references and index. | ||
| 588 | 0 | |a Print version record and CIP data provided by publisher. | |
| 505 | 0 | |a Table of Contents; Wiley Series on Technologies for the Pharmaceutical Industry; Title page; Copyright page; Dedication; Collaborative Drug Discovery Ethos; Foreword; Preface; About the Book; About the Editor; Contributors; Part I: Perspectives on Collaborative Innovation; 1: Productive Relationships in Research and Development between Government, Industry, and Universities; Universities, Government, and Industry: Historical Beginnings in Prussia; Refinement and Broad Adoption: the United States; General Principles for Success; Notes; 2: Divided We Fall; Challenges; Collaboration Models. | |
| 505 | 8 | |a Examples of Successful Biomedical CollaborationsPrinciples of Collaboration; Governance, Administration, and Autonomy; Human Factors; Conclusion; References; 3: Innovation: Open Source and Nonprofit Models in Drug Discovery; Why Do People Innovate?; How Do We Encourage Innovation?; Why Is Innovation Important?; Warnings Regarding Innovation in Drug Discovery; Open Source Models; Nonprofit Models; Recommendations; References; 4: The Changing Face of Innovation in Drug Discovery; Introduction; Core Objectives of the Drug Discovery Process. | |
| 505 | 8 | |a Major Innovations in Technology Have Advanced Drug DiscoveryAn Important Trend: Academic and Pharmaceutical Organizations Are Collaborating in Support of Drug Discovery; Future Perspectives: Where Is Innovation Leading?; References; 5: Current Trends in Collaborative Drug Discovery and Strategies to De-Risk Precompetitive Initiatives; Pharmaceutical Industry's Perspective; Academia's Perspective; Open (Collaborative) Innovation: A New Business Model; Drug Discovery through Collaborations; Drug Discovery through Consortia; Drug Discovery through Repurposing Strategies. | |
| 505 | 8 | |a Probe Discovery in Public DomainEffective Management of Academia-Pharma Collaborations; Concluding Remarks; References; Notes; 6: A Perspective on the Evolution of Collaborative Drug Discovery and Future Challenges; Evolution of Collaborative Drug Discovery; Challenges for Collaborative Drug Discovery; Conclusion; References; Part II: Governmental Initiatives Accelerate Precompetitive Collaboration; 7: The Value of University-Industry Partnerships; Guiding Principles for University-Industry Collaborations; The Johnson Continuum; Role of Cocreation: Companies, Government, and Universities. | |
| 505 | 8 | |a Funding for Collaborations with AcademiaNew Initiatives to Transform University-Industry Collaborations; Issues Affecting University-Industry Collaborations; Differences between Large- and Small-/Medium-Sized Companies; Large Companies Share Certain Characteristics; Small- and Medium-Sized Enterprises (SMEs) Offer a Contrasting Perspective; The National Academies' University-Industry Demonstration Partnership; Strategies for Building High-Value, High Return U-I Partnerships; Conclusion; Note on this Chapter; Note; References. | |
| 520 | |a Can academia save the pharmaceutical industry? The pharmaceutical industry is at a crossroads. The urgent need for novel therapies cannot stem the skyrocketing costs and plummeting productivity plaguing R & D, and many key products are facing patent expiration. Dr. Rathnam Chaguturu presents a case for collaboration between the pharmaceutical industry and academia that could reverse the industry's decline. Collaborative Innovation in Drug Discovery: Strategies for Public and Private Partnerships provides insight into the potential synergy of basing R & D in academia while leaving d. | ||
| 590 | |a ProQuest Ebook Central |b Ebook Central Academic Complete | ||
| 650 | 0 | |a Drug development. | |
| 650 | 0 | |a Public-private sector cooperation. | |
| 650 | 1 | 2 | |a Drug Discovery |
| 650 | 2 | 2 | |a Public-Private Sector Partnerships |
| 650 | 6 | |a Médicaments |x Développement. | |
| 650 | 6 | |a Partenariat public-privé. | |
| 650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a Drug development |2 fast | |
| 650 | 7 | |a Public-private sector cooperation |2 fast | |
| 655 | 0 | |a Electronic books. | |
| 655 | 4 | |a Internet Resources. | |
| 700 | 1 | |a Chaguturu, Rathnam, |e editor. | |
| 758 | |i has work: |a Collaborative innovation in drug discovery (Text) |1 https://id.oclc.org/worldcat/entity/E39PD3XTyGy4RqQhXrpYmTdV98 |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |t Collaborative innovation in drug discovery. |d Hoboken, New Jersey : John Wiley & Sons Inc., [2014] |z 9780470917374 |w (DLC) 2013035525 |
| 830 | 0 | |a Wiley series on technologies for the pharmaceutical industry. | |
| 856 | 4 | 0 | |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=1662193 |z Texto completo |
| 938 | |a Askews and Holts Library Services |b ASKH |n AH26311587 | ||
| 938 | |a Coutts Information Services |b COUT |n 28009480 | ||
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL1662193 | ||
| 938 | |a ebrary |b EBRY |n ebr10856828 | ||
| 938 | |a EBSCOhost |b EBSC |n 752647 | ||
| 938 | |a ProQuest MyiLibrary Digital eBook Collection |b IDEB |n cis28009480 | ||
| 938 | |a Recorded Books, LLC |b RECE |n rbeEB00316112 | ||
| 938 | |a YBP Library Services |b YANK |n 11072575 | ||
| 938 | |a YBP Library Services |b YANK |n 12677264 | ||
| 938 | |a YBP Library Services |b YANK |n 11744583 | ||
| 994 | |a 92 |b IZTAP | ||